[1] |
王锡山.结直肠肿瘤类-NOTES术之现状及展望[J].中华结直肠疾病电子杂志, 2015, 4(4):11-16.
|
[2] |
胡俊杰,周志祥. 直肠癌NOSE手术应用技术及规范[J].实用肿瘤杂志, 2015, 30(3):209-213.
|
[3] |
Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial[J]. Lancet, 2005, 365(9472):1718-1726.
|
[4] |
Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial[J]. Lancet Oncol, 2014, 15(7):767-774.
|
[5] |
Bonjer HJ, Deijen CL, Abis GA, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer[J]. N Engl J Med, 2015, 372(14):1324-1332.
|
[6] |
Cahill R, Lindsey I, Cunningham C. NOTES for colorectal neoplasia–surgery through the looking glass[J]. Gut, 2009, 58(8):1168-1169.
|
[7] |
Franklin ME Jr, Liang S, Russek K. Integration of transanal specimen extraction into laparoscopic anterior resection with total mesorectal excision for rectal cancer: A consecu-tive series of 179 patients[J]. Surg Endosc, 2013, 27(1):127-132.
|
[8] |
Menges P, Kessler W, Kloecker C, et al. Surgical trauma and postoperative immune dysfunction[J]. Eur Surg Res, 2012, 48(4):180-186.
|
[9] |
Schreiber RD, Old LJ, Smyth MJ.Cancer Immunoediting: Integrating Immunity′s Roles in Cancer Suppression and Promotion[J]. Science, 2011, 331(6024):1565-1570.
|
[10] |
Ali AA, McMillan DC, Matalka II, et al.Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer[J]. Eur J Surg Oncol, 2004, 30(3):292-295.
|
[11] |
Joosten SA, Ottenhoff TH. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination[J]. Hum Immunol, 2008, 69(11):760-770.
|